| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Accidental tetracaine poisoning |
Causative agent (attribute) |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Intentional tetracaine poisoning |
Causative agent (attribute) |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| intoxication par la tétracaïne d'intention indéterminée |
Causative agent (attribute) |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to tetracaine |
Causative agent (attribute) |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Amethocaine hydrochloride 2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Amethocaine hydrochloride 1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Amethocaine hydrochloride 0.5% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Amethocaine 4% gel+dressing |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Amethocaine 4% gel+occlusive dressing |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Tetracaine hydrochloride 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Product containing tetracaine in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Tetracaine hydrochloride 0.2%/dextrose 6% injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Tetracaine hydrochloride 0.3%/dextrose 6% injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Tetracaine hydrochloride 20 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Tetracaine hydrochloride 5 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Tetracaine hydrochloride 1% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Tetracaine hydrochloride 10mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Tetracaine hydrochloride 5mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Tetracaine hydrochloride 3mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Product containing tetracaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Poisoning by tetracaine |
Causative agent (attribute) |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Tetracaine measurement |
Component |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate+amethocaine hydrochloride 0.05%/0.015% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine digluconate+amethocaine 0.05/0.015% oral spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Eludril oral spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Benzocaine + butamben + tetracaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Tetracaine hydrochloride |
Is a |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Amethocaine adverse reaction |
Causative agent (attribute) |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Intentional tetracaine poisoning |
Causative agent (attribute) |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Adverse reaction to tetracaine |
Causative agent (attribute) |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing lidocaine and tetracaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine 70mg/tetracaine 70mg transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Product containing chlorhexidine and tetracaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing tetracaine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Product containing tetracaine in oropharyngeal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Tetracaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Accidental poisoning by tetracaine |
Causative agent (attribute) |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to tetracaine |
Causative agent (attribute) |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Tetracaine hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
| Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing tetracaine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing tetracaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing lidocaine and tetracaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine and tetracaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing only tetracaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine and tetracaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only lidocaine and tetracaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Tetracaine only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Tetracaine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Tetracaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Tetracaine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracaine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracaine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing only chlorhexidine and tetracaine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing chlorhexidine and tetracaine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing tetracaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
| Chlorhexidine- and tetracaine-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
| Product containing only chlorhexidine and tetracaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]